Evidence map›Paper›PMID 41073425›Full record

ArticleNPJ genomic medicine2025

A ciliopathy combining Joubert syndrome and Oro-Facial-Digital syndrome caused by bi-allelic 5'-UTR loss-of-function CEP83 variant.

Matan M Jean, Anan Yunis, Tzofit Elbaz-Biton, Vadim Dolgin, Ginat Narkis, Analia Michaelovsky, Marina Eskin-Schwartz, Alexandra A Tsitrina, Nadav Agam, Tomer Poleg and 8 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Matan M JeanThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Anan YunisThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Tzofit Elbaz-BitonThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences and National Institute of Biotechnology in the Negev, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Vadim DolginThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Ginat NarkisThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Analia MichaelovskyFaculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Marina Eskin-SchwartzGenetics Institute, Soroka University Medical Center, Be'er Sheva, Israel.
Alexandra A TsitrinaIlse Katz Institute for Nanoscale Science and technology, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Nadav AgamThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Tomer PolegThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Amit SafranThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Ofek FreundThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Noam HadarThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Dan LevyThe Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences and National Institute of Biotechnology in the Negev, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Ilan ShelefDepartment of Radiology, Soroka University Medical Center, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Khalil El AmourSouthern district, Clalit Health Services, Be'er-sheva, Israel.
Hagit FlusserThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel.
Ohad S BirkThe Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, Israel. obirk@bgu.ac.il.

Funding

Israel Science Foundation 2463/23
6 · The paper itself

Abstract

Oro-Facial-Digital Syndrome (OFDS) and Joubert syndrome are ciliary disorders. Fifteen individuals of consanguineous Bedouin kindred presented with global developmental delay with no speech, and a clear OFDS phenotype, combined with Joubert syndrome, with MRI showing hypoplastic corpus callosum and molar tooth sign. Renal and liver function tests and ultrasound were unremarkable. Within a 0.5 Mb disease-associated locus (LOD score 6.2), whole genome sequencing identified a single variant: CEP83 NG_051825.2:g.5774dupG, (NM_016122.3):c.-278dupG. Patient fibroblasts showed aberrantly long cilia, and alternative splicing of CEP83 5'UTR, skipping most of exon 1 of the canonical transcript, and frameshift, abrogating CEP83 mRNA and protein expression. CEP83 acts in primary cilium assembly. CEP83 biallelic missense or in-frame deletions, with presumed residual function, were previously associated with early-onset nephronophthisis culminating in end-stage renal disease. We now demonstrate that a biallelic complete loss-of-function CEP83 variant culminates in elongated primary cilia, causing OFDS with Joubert-like features without evident renal involvement.

Identifiers

PMID41073425
PMCPMC12514222

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.